Piperoxan
File:Piperoxan.png | |
Systematic (IUPAC) name | |
---|---|
1-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)piperidine | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
59-39-2 135-87-5 (hydrochloride) |
ATC code | none |
PubChem | CID 6040 |
ChemSpider | 5817 |
Chemical data | |
Formula | C14H19NO2 |
Molar mass | 233.31 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
Piperoxan, also known as benodaine or benzodioxane, is a drug which was the very first antihistamine ever to be discovered.[1][2] It was prepared in the early 1930s by Daniel Bovet and Ernest Fourneau at the Pasteur Institute in France.[1][2] Formerly investigated by Fourneau as an α-adrenergic-blocking agent, they demonstrated that it also antagonized histamine-induced bronchospasm in guinea pigs, and published their findings in 1933.[1][2][3] Bovet went on to win the 1957 Nobel Prize in Physiology or Medicine for his contribution,[4] and one of their students, Anne-Marie Staub, published the first structure-activity relationship (SAR) study of antihistamines in 1939.[1]
See also
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
Aminoalkyl ethers | |
---|---|
Substituted alkylamines | |
Substituted ethylenediamines | |
Phenothiazine derivatives | |
Piperazine derivatives | Buclizine • Cetirizine • Chlorcyclizine • Cinnarizine • Cyclizine • Hydroxyzine • Levocetirizine • Meclizine • Niaprazine • Oxatomide |
Others for systemic use | Antazoline • Azatadine • Bamipine • Cyproheptadine • Deptropine • Dimebon • Ebastine • Epinastine • Ketotifen • Mebhydrolin • Mizolastine • Phenindamine • Pimethixene • Pyrrobutamine • Rupatadine • Triprolidine • selective (Acrivastine • Astemizole • Azelastine • Desloratadine • Fexofenadine • Loratadine • Terfenadine) |
For topical use | |
Antiallergic agents excluding corticosteroids | |
Other antiallergics |
Receptor ligands |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Reuptake inhibitors |
| ||||||||||
Enzyme inhibitors |
| ||||||||||
Others |
- ↑ 1.0 1.1 1.2 1.3 Scriabine, Alexander; Landau, Ralph; Achilladelis, Basil (1999). Pharmaceutical innovation: revolutionizing human health. Philadelphia: Chemical Heritage Press. ISBN 0-941901-21-1. CS1 maint: Multiple names: authors list (link)
- ↑ 2.0 2.1 2.2 Williams, David H.; Lemke, Thomas L.; Foye, William O. (2008). Foye's principles of medicinal chemistry. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-6879-9. CS1 maint: Multiple names: authors list (link)
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
- ↑ "Daniel Bovet - Biography".
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Alpha blockers
- Antihistamines
- Piperidines
- Benzodioxins
- 2Fix
- CS1 maint: Multiple names: authors list